Cargando…
Mitochondria-acting carrier-free nanoplatform self-assembled by α-tocopheryl succinate carrying cisplatin for combinational tumor therapy
Unsatisfactory drug loading capability, potential toxicity of the inert carrier and the limited therapeutic effect of a single chemotherapy drug are all vital inhibitory factors of carrier-assisted drug delivery systems for chemotherapy. To address the above obstacles, a series of carrier-free nanop...
Autores principales: | Mei, Heng, Li, Jing, Cai, Shengsheng, Zhang, Xuequan, Shi, Wenqiang, Zhu, Hai, Cao, Jun, He, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242230/ https://www.ncbi.nlm.nih.gov/pubmed/34221448 http://dx.doi.org/10.1093/rb/rbab029 |
Ejemplares similares
-
Selective cancer cell killing by α-tocopheryl succinate
por: Neuzil, J, et al.
Publicado: (2001) -
An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy
por: Lee, Song Yi, et al.
Publicado: (2018) -
Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases
por: Srivastava, Ajay, et al.
Publicado: (2019) -
Intraperitoneal administration of nanoparticles containing tocopheryl succinate prevents peritoneal dissemination
por: Hama, Susumu, et al.
Publicado: (2022) -
Tocopheryl Succinate-Induced Structural Changes in DPPC Liposomes: DSC and ANS Fluorescence Studies
por: Neunert, Grażyna, et al.
Publicado: (2020)